7/5/2007

Congress seeks to balance drug safety with speedy FDA approval of new drugs as it considers renewal of the Prescription Drug User Fee Act. The 15-year-old program has saved lives and boosted industry profits, but some experts urge more focus on post-market drug surveillance.

Related Summaries